Mizuno Atsushi, Matsumoto Chisa, Yoneoka Daisuke, Kishi Takuya, Ishida Mari, Sanada Shoji, Fukuda Memori, Saito Yoshihiko, Yamauchi-Takihara Keiko, Tsutsui Hiroyuki, Fukuda Keiichi, Komuro Issei, Node Koichi
Department of Cardiology, St. Luke's International Hospital Tokyo Japan.
Penn Medicine Nudge Unit, University of Pennsylvania Philadelphia, PA USA.
Circ Rep. 2021 Feb 5;3(3):137-141. doi: 10.1253/circrep.CR-21-0002.
From the early phase of the Coronavirus disease-2019 (COVID-19) pandemic, cardiologists have paid attention not only to COVID-19-associated cardiovascular sequelae, but also to treatment strategies for rescheduling non-urgent procedures. The chief objective of this study was to explore confirmed COVID-19 cardiology case experiences and departmental policies, and their regional heterogeneity in Japan. We performed a retrospective analysis of a nationwide survey performed by the Japanese Circulation Society on April 13, 2020. The questionnaire included cardiology department experience with confirmed COVID-19 cases and restriction policies, and was sent to 1,360 certified cardiology training hospitals. Descriptive analysis and spatial autocorrelation analysis of each response were performed to reveal the heterogeneity of departmental policies. The response rate was 56.8% (773 replies). Only 16% of all responding hospitals experienced a COVID-19 cardiology case. High-risk procedures were restricted in more than one-fifth of hospitals, including transesophageal echocardiography (34.9%) and scheduled catheterization (39.5%). The presence of a cardiologist in the COVID-19 team, the number of board-certified cardiologists, any medical resource shortage and a state of emergency were positively correlated with any type of restriction. We found both low clinical case experiences with COVID-19 and restrictions of cardiovascular procedures during the first COVID-19 wave in Japan. Restrictions arising as a result of COVID-19 were affected by hospital- and country-level variables, such as a state of emergency.
从2019冠状病毒病(COVID-19)大流行的早期阶段开始,心脏病专家不仅关注与COVID-19相关的心血管后遗症,还关注重新安排非紧急手术的治疗策略。本研究的主要目的是探讨日本确诊的COVID-19心脏病病例经验和科室政策及其区域异质性。我们对日本循环学会于2020年4月13日进行的一项全国性调查进行了回顾性分析。问卷包括心脏病科确诊COVID-19病例的经验和限制政策,并发送给1360家认证心脏病培训医院。对每个回复进行描述性分析和空间自相关分析以揭示科室政策的异质性。回复率为56.8%(773份回复)。所有回复医院中只有16%遇到过COVID-19心脏病病例。超过五分之一的医院限制了高风险手术,包括经食管超声心动图(34.9%)和预定的导管插入术(39.5%)。COVID-19团队中有心脏病专家、获得委员会认证的心脏病专家数量、任何医疗资源短缺和紧急状态与任何类型的限制呈正相关。我们发现在日本第一波COVID-19疫情期间,COVID-19的临床病例经验较少,心血管手术也受到限制。COVID-19导致的限制受到医院和国家层面变量的影响,如紧急状态。